Business Wire

Seda Packaging Group: Revolutionary New Paper Lid Delivers Integrated Sustainable Drinking Solutions

23.1.2025 06:00:00 CET | Business Wire | Press release

Share

Seda International Packaging Group’s versatile new EcoFit Lids offer complete plastic reduction and the lowest energy and water consumption manufacturing process

In a radical development significantly advancing sustainability, Seda International has proudly introduced its innovative EcoFit Lid on the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122180654/en/

null

The compostable Double Wall cold cups with EcoFit lids for a superior beverage experience (Photo: Luciano Romano)

The EcoFit Lid has been thoughtfully designed to completely replace traditional plastic lids with a leak- and spill-resistant solution that delivers a superior drinking experience for hot and cold beverages alike. Enhancing safety, an audible snap confirms it has engaged fully with the cup rim for a secure, tight fit that’s better both in-store and during delivery.

Conceived following Seda’s rigorous ecodesign principles, the EcoFit Lid is also an exceptionally flexible and versatile solution. Available in Flat & Domed options, each offers a choice of triangular or oval sip hole with either a C-cut, cross-cut or Push & Lift action to provide a fully-tailored consumer experience and brand personality.

Crafted from 100% certified renewable fibres, the EcoFit lid can be combined with Seda’s cutting-edge printing technology to offer exceptional branding opportunities. It has the lowest environmental impact of any fibre lid in terms of CO₂ Emissions and Water Consumption for the entire supply chain, from cradle to grave.

A Life Cycle Assessment (LCA) conducted using EU data has conclusively demonstrated the EcoFit lid's superiority over other lid options, including moulded fibre and plastic PS and PP lids. This was confirmed by a recent Seda gate-to-gate screening showing EcoFit’s substantial environmental benefits, including significantly lower production cycle water and energy consumption as well as carbon emissions than even moulded fibre lids.

Fully recyclable in the paper stream and also available in a compostable version to meet all needs and usage scenarios, the EcoFit Lidis set to massively reduce the depletion of fossil resources caused by current plastic lids, saving 400 tons of plastic for every 100 million lids.

Brands can consequently make measurable progress towards reducing their environmental impact by choosing EcoFit Lids to support their sustainability goals and contribute to a lower carbon footprint in the packaging supply chain.

Equally important, the EcoFit Lid is not an isolated solution but has been expressly designed to form an integrated, fully sustainable package with Seda’s Double Wall cups. An original Seda innovation developed for hot beverages and patented in the early 2000s, the Double Wall Cup has set the industry standard ever since.

Seda’s more recently introduced Double Wall Cold Cups are made from the same sustainable, printable paperboard and have likewise been conceived to deliver a superior drinking experience. Their unique, patented air gap design ensures beverages stay cold for longer, while greatly reducing condensation and sweating to provide a much more enjoyable tactile sensation compared with single wall cold cups made of paper or plastic. Consumers appreciate how their drinks remain cool and satisfying without worrying about condensation or slippery cups, making each sip as refreshing as the first.

These cups and lids have been specifically designed to meet the growing demands of evolving legislation across Europe that increasingly favours sustainable packaging solutions. Seda’s new offering thus provides a transformative solution for businesses that need to rapidly adapt to new environmental regulations.

“Our new EcoFit Lids and compostable Double Wall cold cups underscore Seda Group’s dedication to continuous innovation and sustainability,” said Armando Mariano, Director of Innovation, R&D, Materials, and Sustainability at Seda Group. “These products were designed with the future in mind, addressing environmental concerns and evolving consumer demands. By significantly reducing water consumption and CO2 emissions, our EcoFit Lid sets a new benchmark in sustainable beverage packaging. We are proud to offer solutions that not only comply with stringent regulations but also enhance the consumer experience while helping brands make meaningful progress towards their sustainability goals.

As European consumers increasingly demand more sustainable products, Seda continues to lead the market with the most innovative and sustainable packaging solutions, consistently delivering top-quality products that meet customer expectations with outstanding service.

Leading coffee, restaurant, and convenience store brands worldwide are already adopting these innovations to meet their sustainability objectives.

Seda International Packaging Group is a leading provider of sustainable food and food service packaging solutions. Headquartered in Naples, Italy, Seda operates manufacturing platforms across Italy, Germany, Portugal, the UK and North America.

Discover more about Seda at www.sedagroup.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250122180654/en/

null
null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release

First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release

Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures

IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release

IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye